Cranial neural crest Neural Metalloproteases A B S T R A C T ADAM19 is a member of the meltrin subfamily of ADAM metalloproteases. In Xenopus, ADAM19 is present as a maternal transcript. Zygotic expression starts during gastrulation and is apparent in the dorsal blastopore lip. ADAM19 expression through neurulation and tailbud formation becomes enriched in dorsal structures such as the neural tube, the notochord and the somites. Using morpholino knock-down, we show that a reduction of ADAM19 protein in gastrula stage embryos results in a decrease of Brachyury expression in the notochord concomitant with an increase in the dorsal markers, Goosecoid and Chordin. These changes in gene expression are accompanied by a decrease in phosphorylated AKT, a downstream target of the EGF signaling pathway, and occur while the blastopore closes at the same rate as the control embryos. During neurulation and tailbud formation, ADAM19 knock-down induces a reduction of the neural markers N-tubulin and NRP1 but not Sox2. In the somitic mesoderm, the expression of MLC is also decreased while MyoD is not. ADAM19 knockdown also reduces neural crest markers prior to cell migration. Neural crest induction is also decreased in embryos treated with an EGF receptor inhibitor suggesting that this pathway is necessary for neural crest cell induction. Using targeted knockdown of ADAM19 we show that the reduction of neural and neural crest markers is cell autonomous and that the migration if the cranial neural crest is perturbed. We further show that ADAM19 protein reduction affects somite organization, reduces 12-101 expression and perturbs fibronectin localization at the intersomitic boundary.
Introduction
Post-translational modification of proteins is a critical step in most biological processes. Among these modifications, cleavage of cell surface proteins control a diverse range of cellular processes such as cell signaling, cell adhesion and cell migration. One family of metalloproteases, ADAM (protein containing A Disintegrin and A Metalloprotease (Wolfsberg et al., 1995) , is responsible for modulating various signaling pathways by shedding membrane bound growth factors and/or their receptors (Blobel, 2005; Huovila et al., 2005; Moss and Lambert, 2002) . In addition, ADAMs have also been shown to cleave cell adhesion molecules such as cadherins to promote epithelial to mesenchymal transition (EMT) essential for proper embryonic development Reiss et al., 2006 Reiss et al., , 2005 .
ADAM19 is a member of the meltrin subfamily and has been shown, in mouse, to cleave TNF-a, Kit1 Ligand, TRANCE, 0925-4773/$ -see front matter Ó 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2008.10.010 HB-EGF and neuregulin-1 (Chesneau et al., 2003; Horiuchi et al., 2005; Kawaguchi et al., 2007; Shirakabe et al., 2001) The knockout (KO) of ADAM19 has been shown to induce defects in heart development, believed to be due to defective HB-EGF signaling (Kurohara et al., 2004; Zhou et al., 2004) . Conditional KO of ADAM19 in the cardiac neural crest cells reproduced the heart phenotype suggesting that ADAM19 is critical for cardiac neural crest cell specification and/or function but not migration (Komatsu et al., 2007) . In mouse, the main enzyme responsible for the cleavage of both HB-EGF, and neuregulin-1 appears to be ADAM17. In addition, mice lacking ADAM17 show very similar heart defects to ADAM19 KO mice. Furthermore, a double knock out of both ADAM17 and 19 results in a more severe phenotype demonstrating possible functional compensation of these ADAMs during embryonic development (Horiuchi et al., 2005) . Fibroblasts derived from ADAM19 KO mice do process both neuregulin-1 and HB-EGF, suggesting that the ADAM19 substrate responsible for its phenotype remains to be identified.
To test whether ADAM19 has a unique role during early embryonic development, we have cloned the Xenopus laevis homologue and analyzed its expression pattern. XADAM19 is present at low levels as a maternal transcript with zygotic expression beginning during gastrulation and localizing to the dorsal blastopore lip. During later stages of embryonic development, ADAM19 is expressed in the dorsal mesoderm, neuroectoderm and neural crest cells. Loss of function experiments using antisense morpholino knock-down reveals that the protein is essential for the specification of the dorsal mesoderm, neuronal derivatives and cranial neural crest cells. The apparent lack of functional compensation for ADAM19 in X. laevis may help resolve the biologically relevant substrate for ADAM19 during early embryonic development.
Results

ADAM19 is expressed both maternally and zygotically
We have cloned the X. laevis homologue of ADAM19 using degenerate oligonucleotides to human, mouse, quail and the genomic sequence of X. tropicalis. The full-length sequence was generated by 5 0 -and 3 0 -RACE-PCR and assembled from multiple PCR amplicons. The deduced amino acid sequence is 49% identical to human ADAM19 and 84% identical to X. tropicalis ADAM19. We found several variants in the cytoplasmic domain at the amino acid level, one of which is most common to the X. tropicalis sequence and was submitted to GenBank (EU770696). Amplification using multiple primers from genomic DNA suggests that one intron-less allele is present in the X. laevis genome (data not shown). We investigated ADAM19 expression throughout development using real-time PCR. Since the genomic DNA appears to contain a copy of the gene lacking introns, we used polyA purified mRNA to eliminate any trace of genomic DNA in our samples. ADAM19 is expressed both maternally and zygotically from gastrulation through early tailbud formation (Fig. 1) . The expression level of ADAM19 at gastrulation is low but is confirmed by in situ hybridization where it appears restricted to the dorsal lip of the blastopore ( Fig. 2A) .
2.2.
ADAM19 mRNA is enriched in dorsal structures including somites, neural tube and cranial neural crest cells Using whole mount in situ hybridization, we investigated the distribution of ADAM19 transcript during gastrulation, neurulation and tailbud formation (Fig. 2) . To avoid background staining due to either antibody or substrate precipitation in the blastocoel, we performed in situ hybridization on hemi-gastrula embryos. At stage 12, the mRNA encoding ADAM19 is mostly localized to the dorsal lip of the blastopore where the dorsal mesoderm invaginates ( Fig. 2A) . During early tailbud stages, ADAM19 is expressed in the dorsal region of the embryo including the neural tissue and the dorsal mesoderm. ADAM19 is detected in the neural tube, the notochord and the cement gland (Fig. 2B, C and F) . In the mesoderm, ADAM19 is expressed both in the segmented (somite) and non-segmented (caudal) dorsal mesoderm ( Fig. 2G and H). When stained embryos are observed in PBS rather than Murray's clear to visualize superficial staining, ADAM19 is detected in the segments of the cranial neural crest cells (CNC, Fig. 2I ). The expression in the CNC cells was confirmed by RT-PCR on explants dissected from stage 17 embryos (Fig. 2I insert) . At stage 26, ADAM19 expression is evident in the cement gland, the brain, the somites, the otic vesicle and the branchial arches (Fig. 2D) . At stage 36 ADAM19, is still expressed in the entire head, the branchial arches and the Fig. 1 -ADAM19 expression. Quantitative real-time PCR expression of ADAM19 during early Xenopus development. Polyadenylated RNA from 2.5 embryos was used to make cDNA. PCR amplification was performed on a light cycler for 40 cycles. (A) The amplification product from both the control (ÀRT) and the experimental (+RT) were separated on a 2% agarose gel. (B) The relative abundance of the ADAM19 mRNA was measured by the 2 ðÀDCTÞ method using stage 10 as somites (Fig. 2E) . The staining intensity decreases in the somite and by contrast appears stronger in the neural tube. In addition, the expression appears within the pronephros (p).
Morpholino antisense oligonucleotides to ADAM19 reduces endogenous protein levels
To perform loss of function experiments, we designed antisense morpholino oligonucleotides corresponding to the sequence near the ATG start codon and common to all sequences identified (5 0 -RACE amplicons). We also generated a polyclonal antibody to the cytoplasmic domain of the two variants cloned for ADAM19. This antibody recognized the cloned ADAM19 in both transfected Cos-7 extract and embryos injected with the ADAM19 mRNA ( Fig. 3C and data not shown). The antibody also recognizes a 120 kDa polypeptide expressed in embryos at stage 24 but absent at stage 7 (Fig. 3A) together with additional lower bands present at all stages and most likely not specific. In embryos injected with ADAM19 MO (MO19) the polypeptide at 120 kDa recognized by the antibody is reduced by 60-90%, depending on the injection, when compared to the b1 integrin subunit ( Fig. 3A and B). In addition to the 120 kDa band, a higher molecular weigh product recognized by the antibody is also decreased by the MO. This band could correspond to either a splicing variant or a protein with different post-translational modifications. In addition to the endogenous protein, MO19 prevents translation of the ADAM19 mRNA while a morpholino to ADAM13 (MO13) does not (Fig. 3C , MO19 + A19 and MO13 + A19). Mutation of four nucleotides in the ADAM19 mRNA allows translation of the protein in injected embryos (Fig. 3C , MO19 + A19R). While translation of this mRNA is still affected by the MO19 (compare lane 2 to lane 4), it generates amount of ADAM19 protein that are in excess compared to the endog- enous protein (compare lane 4 to NI lane 1). We believe that the 4 nucleotides changes (out of 26) may still allow binding of the MO to the mRNA when both are concentrated in a tube before the injection. This construct named ADAM19 Rescue (A19R) was used in all of the rescue experiments. Before performing phenotypic analyses of ADAM19 knock-down, we tested by microinjection the effect of 1, 5, 10, 25 and 50 ng of MO19 per embryos. At the highest dose of 50 ng per embryos, most embryos cleaved and underwent gastrulation, however at the end of neurulation a significant percentage failed to close their neural tube and died (data not shown). While this dose produced significant death, we did not see a decrease of the 120 kDa protein more significant than with 10 ng of MO19. For this reason we selected 10 ng in all subsequent experiments.
2.4.
ADAM19 reduction has no effect on blastopore closure but affects Brachyury expression in the notochord Gastrulation is one of the most sensitive stages of early development and can easily be perturbed by a variety of specific or non-specific treatments to the embryo. To investigate the affect of ADAM19 knock-down on gastrulation, we first measured the size of the blastopore during gastrulation. Using the average diameter of the blastopore, we found that embryos injected with MO19 closed their blastopore at the same rate as embryos injected with a control morpholino (Fig. 4) . As previously stated, ADAM19 mRNA is found in the dorsal blastopore lip, therefore we tested whether the knock-down of ADAM19 perturbed the expression of early developmental markers (Fig. 5 ). We first investigated Brachyury expression (Xbra) in morphant embryos at stage 12 by whole mount in situ hybridization (Fig. 5A ). Our results show that Xbra is expressed in the ventral and lateral mesoderm but is missing in the notochord of 63% of the embryos with reduced ADAM19 protein (n = 30). To test whether the dorsal mesoderm was entirely missing, we assessed Chordin and Goosecoid expression in the notochord and cephalic mesenchyme respectively. At stage 12, we found that most embryos (65% n = 30) had the same expression of chordin while 35% showed a reduced staining. In contrast, 76% of the embryos injected with MO19 had the same level of Goosecoid staining while the remaining 24% (n = 20) showed a wider expression. Another notochord marker (not-1) was not affected by the knockdown of ADAM19 (data not shown). These results show that the dorsal mesoderm and the notochord are present in embryos with reduced level of ADAM19 but that the patterning of the notochord may be altered.
Using quantitative real-time PCR, we tested the level of expression of these genes in embryos injected with a control MO, MO19 and a combination of MO19 and ADAM19 Rescue mRNA (Fig. 5B) . The results confirm a small reduction of Xbra expression (16% decrease) possibly due to the absence of expression in the notochord. In contrast, we found that both Chordin and Goosecoid levels were increased by about two Quantitative real-time PCR was performed on embryos injected with either MO19 alone or together with ADAM19 Rescue mRNA (MO19 + A19R). The relative abundance of Chordin (Chd), Goosecoid (Gsc) and Brachyury (XBra) gene expression was measured by the 2 ðÀÞ method using either embryos injected with the control MO or non-injected and normalized to a-tubulin.
There was no effect of the control MO to gene expression. The asterisks represent statistical significance at P < 0.05 using a Student t test. There is a small decrease in Xbra (16%, not significant) and a robust increase in both Chd (187%) and Gsc (230%) which are rescued by the injection of the ADAM19 mRNA.
folds in embryos with reduced ADAM19 protein suggesting that there is in fact an increase in certain dorsal mesoderm markers. These changes in gene expression were all rescued by the injection of ADAM19R mRNA. While the Goosecoid and Xbra results correlate nicely between the in situ and the real-time PCR, the results for Chordin do not. One simple explanation is that in situ hybridization is not a quantitative technique and a two folds increase may not be detectable using this technique. Another possible explanation is that the expression of Chordin is wider but that the level in individual cells either remain the same or decrease slightly. This would appear by in situ hybridization as a decrease while the quantitative PCR would detect the increase.
While the expression of Xbra in the notochord is decreased, we have found using targeted injection at the 8-cell stage and b-galactosidase as a lineage tracer that cells with reduced level of ADAM19 can still be included in the notochord and the somite, suggesting that ADAM19 expression is not essential for the formation of these tissues (data not shown).
Reduction of ADAM19 protein does not interfere with neural induction but inhibits neural crest induction
To test the effects of the knock-down of ADAM19 on neural induction, we performed in situ hybridization using Sox2 as a general neural marker. The results show that MO19 does not prevent neural induction (Fig. 5) . While the overall expression of Sox2 was not affected, careful analysis reveal some subtle changes. For example, while Sox2 expression in control embryos is lighter in the neural plate directly above the notochord (future floor plate, Fig. 5A , red arrowhead), this decrease of Sox2 at the midline is not visible in 30% of the embryos injected with MO19 (n = 30), suggesting that a reduction in ADAM19 protein may affect axial tissue patterning across the mesoderm/neuroectoderm tissue boundary. However, at that point it is not clear whether the effect on the neural plate is direct or the result of a defective signaling from the notochord.
ADAM19 is also expressed in the CNC cells, therefore we performed in situ hybridization and real-time PCR at the open neural plate stage (stage 15) before CNC migration to test if ADAM19 was essential for neural crest induction (Fig. 6) . Our results show that both Sox8 and Slug are reduced following injection of MO19 but not a control MO (Fig. 6A) . Real-time PCR shows a reduction of about two fold for Sox8 (50% reduction) and Slug (40% reduction; Fig. 6B ). In contrast, the neural marker Sox2 increased rather than decreased at this early stage. Since neural crest is induced at the border of the neural plate, it is likely that the cells that are not induced to become neural crest will maintain Sox2 expression.
To test the ability of CNC cells with reduced ADAM19 to migrate, we also performed targeted injection of the MO19 together with GFPmRNA at the 16-cell stage in a dorso-lateral animal blastomere. Cell migration was evaluated by observing the distribution of GFP in the different CNC segments (Fig. 6C) . Our results show that, while GFP is found in CNC that migrate in all segments in control embryos, no migration was observed in 33% of the embryos injected with MO19. Together these results show that ADAM19 is required for neural crest cell induction and migration. It is likely that the defect observed for CNC migration is due to the defect in induction but we cannot rule out that ADAM19 may also have an independent role in cell migration.
At later stages, our results show that there is a significant reduction of xTwist expression in the MO19 injected side (Fig. 7A, arrowhead) . To test if the knock-down affects the CNC specification or just xTwist expression we used ADAM11 as a marker of CNC in quantitative PCR experiments. While Twist is a widely used marker for CNC by in situ hybridization, it also labels other cells at the tailbud stage. On the other hand, ADAM11 is more restricted with expression in both the CNC and one line of dorsal neurons (Cai et al., 1998) . Confirming the in situ hybridization, we observed a decrease of ADAM11 expression at both stages 17 (58%) and 24 (50%) (Fig. 7B ). This expression can be rescued with ADAM19 rescue mRNA. To test if the effect on neural crest induction was direct, or a result from the abnormal mesoderm patterning, we injected the embryos at the 8 cell stage in both animal dorsal blastomere (Fig. 7C, right) . The results show that ADAM11 is decreased while the MLC is not confirming that ADAM19 role in neural crest induction is direct.
ADAM19 knock-down reduces muscle specification
The expression of ADAM19 increases at neurula and tailbud stages and is mainly concentrated in the dorsal mesoderm and neural tissue. To understand the effects of a reduction in the ADAM19 protein on embryonic development, we performed in situ hybridization using MLC, MyoD, N-tubulin, Sox2 and NRP-1 at the tailbud stage (stage 24). Embryos were injected in one blastomere of the two-cell stage with 10 ng of either control MO (CMO) or MO19 with mRNA encoding b-galactosidase (Fig. 7A) . The results show that ADAM19 knock-down dramatically reduces MLC expression in the somites. In contrast, MyoD, which is also expressed in the somites, did not appear to be reduced on the injected side. In addition, MyoD staining shows that the correct somites segmentation is achieved even in the presence of the ADAM19 MO. The reduction of MLC expression was confirmed by quantitative PCR (Fig. 7B ). This reduction was strongest at stage 17 (93%) but also evident at stage 24 (58% decrease). In addition, both were rescued by the expression of the ADAM19 mRNA (Fig. 7B) . In fact, the same pattern of gene expression (reduction of MLC but no changes in MyoD) was also observed at stage 15 (data not shown). These results suggest that a reduction in the ADAM19 protein level does not affect early induction and segmentation (MyoD) of the somititic mesoderm but may interfere with the differentiation of the muscle (MLC).
Reduction of ADAM19 protein affects neural patterning
To test the effect of ADAM19 knock-down in the neural tissue, we used Sox2 and NRP1 as general neural markers and N-tubulin as a marker of neuronal precursors. In situ hybridization at the tailbud stage shows that Sox2 was unaffected by a reduction in ADAM19 protein while both N-tubulin and NRP1 appear reduced on the injected side (Fig. 7A) . The reduction of N-tubulin expression was confirmed by quantitative real-time . Alternatively, the MO19 was injected in 2 dorsal-animal blastomeres at the 8-cell stage (MO19 Ectoderm) to target dorsal ectoderm but not mesoderm derivatives. All genes were compared to non-injected control embryos. The relative abundance of MLC, N-tubulin, Sox2 and ADAM11 gene expression was measured by the 2 ðÀDCTÞ method and normalized to a-tubulin. Results are presented as the log 2 of the fold change. Error bar correspond to the standard error. Asterisks represent a P < 0.05 using a standard t test assuming unequal variance.
PCR at both stages 17 and 24 (Fig. 7B ). While the decrease was small (30%), it was highly reproducible (P < 0.05) and was fully rescued by the injection of ADAM19R mRNA. This suggests that only a fraction of neurons expressing N-tubulin are affected by the ADAM19 knock-down. In contrast to N-tubulin, ADAM19 knock-down had no effect on Sox2 expression at both stage 17 or 24 confirming the in situ hybridization results.
2.8.
Changes in neural and neural crest markers are not due to secondary defect of the dorsal mesoderm patterning
To investigate whether the reduction of the neural and neural crest markers were due to the reduction of ADAM19 in these tissues or a secondary effect of the dorsal mesoderm patterning, we injected MO19 in both dorsal animal cells at the 8-cell stage to target only ectodermal derivatives (Fig. 7B , right graph). Only 1 ng of MO19 was injected in each cell at that stage to account for the reduction in cell size. The results show that a reduction of ADAM19 protein in the ectoderm is sufficient to reduce N-tubulin and ADAM11 in the same proportion as those observed when the MO19 is injected at the one cell stage. In contrast no change was observed in the somitic mesoderm marker MLC, confirming the proper targeting of our injection. These results suggest that ADAM19 is required in the neural ectoderm and neural crest cells to perform its function.
ADAM19 is required for proper somite organization
To further study the role of ADAM19 in somite formation, we first use the ADAM19 antibody to detect the protein localization on sections of tailbud stage embryos (Fig. 8) . We found that ADAM19 localizes to the notochord, the intersomitic boundary and the ventral half of the neural tube ( Fig. 8A-C) . We also found some staining within the branchial arches (Fig. 8A) . The distribution of the protein is consistent with the mRNA expression pattern (Fig. 2 ) and provides new information about where the protein may be acting. In addition, we performed the same staining on embryos injected on one side with MO19. The most dramatic change is the complete absence of ADAM19 staining at the intersomitic junction (Fig. 8D) . As seen for the in situ hybridization with MyoD (Fig. 7A) , the segmentation of the somites is apparent in both sides of the embryos. While this metamerization is conserved, the organization of the cells within each somite is abnormal in embryos with reduced ADAM19 protein. While the nuclei on the control side are aligned at the center of each cell, the alignment is disrupted on the side with reduced ADAM19 (Fig. 8D) . In addition to this disruption, staining with mAb 12-101, a marker of muscle differentiation, is decreased on the MO19 injected side (Fig. 8E) . This decrease was observed in the posterior somites but not in the most anterior ones suggesting a delay in 12-101 expression rather than a complete inhibition (data not shown). This decrease of 12-101 expression was confirmed by Western blot on embryos injected at the one cell stage with MO19 (Fig. 8G) . Finally, to visualize the intersomitic boundary of embryos injected with the MO19, we performed staining with antibodies to fibronectin (FN). The staining confirms the presence of somite boundaries in the injected side similar to the control side. Interestingly, we also found that some of the boundaries lacked FN (Fig. 8F) . This was confirmed by whole mount immunostaining in which the entire embryo can be visualized at once (Fig. 8H) . Using this technique we found that the fibronectin staining was present but abnormal. The defect was seen only in the somites located between the ''chevron'' and the ''straight'' shaped somites (approximately 7th somite). Compared to this mild and restricted FN defect, the abnormal distribution of the nuclei affected a larger number of somites. Together, the results presented in Fig. 7 and 8 show that a reduction of the ADAM19 protein affects both the organization and differentiation of somitic cells into muscle but not the initial induction of the paraxial mesoderm or its metamerization.
ADAM19 knock-down affects EGF signaling
The best characterized targets of ADAM19 in mouse are members of the epidermal growth factor family (EGF). Upon cleavage ligands bind to the EGF receptor and activate a signaling cascade involving AKT/PKB (protein kinase B). To test if this pathway was affected by the ADAM19 MO, we performed Western blot at stage 12 with embryos injected with the control MO or MO19. Our results show that phosphorylated AKT (pAKT) is decreased significantly in embryos with reduced ADAM19 protein (Fig. 9) . In contrast neither phosphorylated MAPK nor the cytoplasmic adaptor protein PAC-SIN2 was reduced. To test whether the EGF pathway was involved in neural crest cell induction, we used a pharmacological inhibitor of the EGF receptor (AG1478, 100 lM) and treated embryos between stages 10 and 12. In addition we protein is localized to the intersomitic boundary (arrowhead), the notochord (n), the neural tube (nt) and in the branchial arches (ba). (B) Transverse section. ADAM19 is in red, the muscle marker 12-101 in green and the nuclei (DAPI) in blue. ADAM19 staining appears associated with the ventral basal side of the neural tube (arrowhead) and the notochord (n). (C) Magnification of the somite from a frontal section, ADAM19 is in red, the arrowhead points to the intersomitic boundary. (D-F) Frontal sections of tailbud stage embryos injected at the two-cell stage in one cell with 5 ng of MO19. The injected side is labeled (yellow dots) and was detected either by using the ADAM19 antibody (D and E) or GFP-myc (F) that was co-injected with the MO19. The injection of MO19 completely abolished staining of the intersomitic boundary by the ADAM19 antibody. While the intersomitic boundary is still visible, the nuclei are not aligned on the injected side (white line). (E) ADAM19 is in green (left), 12-101 in red (center) and the merge presented with DAPI staining (right). There is a clear reduction of 12-101 staining on the injected side (MO19). (F) The MO19 was co-injected with GFP-myc to detect the cells that were targeted using the 9E10 mAb. Positive cells are visible in the right somites and some of the cells that contribute to the notochord (n). Fibronectin was detected using a rabbit pAb (32F). Some of the FN staining is absent in part of the intersomitic boundary (arrowhead). (G) Western blot using 12-101 on total protein extract. Stage 7 extract is used as a negative control. At stage 22, MO19 injected embryos but none of the other injected embryos have less 12-101 protein. (H) Whole mount immunostaining using mAb 4H2 to detect fibronectin. The injected side was detected prior to fixation using GFP fluorescence. The side injected with the MO19 shows an abnormal pattern of FN staining at some of the intersomitic boundary (arrowhead). b also used a broad-spectrum inhibitor of metalloprotease (Marimastat 10 lM) that inhibits most ADAM proteases activity. Based on the blastopore size, neither inhibitor affected gastrulation movements (data not shown). Using real-time PCR we found that both Marimastat and AG1478 significantly decreased Slug expression confirming the importance of the EGF signaling pathway and metalloprotease activity in neural crest cell induction. As a control, we performed Western blot with the pAKT antibody and found a 50% reduction in embryos treated with the EGF receptor inhibitor confirming its activity in vivo. Similar to what was observed with MO19 ( Fig. 9A-B) , we also found that Marimastat reduced the level of phosphorylated AKT (data not shown), suggesting that one metalloprotease, possibly ADAM19, is essential for EGF signaling during gastrulation.
Discussion
This study reports the cloning and molecular analysis of the X. laevis homologue of ADAM19. The ADAM19 mRNA is present during the initial cleavage stages. Zygotic expression is detected during gastrulation and appears to be enriched in the dorsal blastopore lip. During later development, ADAM19 mRNA is localized to dorsal structures including the dorsal mesoderm and neural derivatives. Loss of function experiments using antisense morpholino oligonucleotides show a reduction of Brachyury in the notochord of gastrula stage embryos and an increase in dorsal markers such as Goosecoid and Chordin. During neurulation and tailbud formation a reduction of ADAM19 protein results in the reduction of neuronal, neural crest and somitic markers. The metamerization of somites is not perturbed but the organization of cells within each somite is. We present evidence that the EGF signaling pathway is affected by ADAM19 knock-down.
ADAM19 gene expression
ADAM19 mRNA is expressed during early mouse embryonic development in a pattern similar to the one described here in Xenopus. It is found in dorsal tissues including the spinal chord, craniofacial and dorsal root ganglia, as well as peripheral neuronal cells. It is also found in mesenchymal condensation specifically in the tailbud and heart (Kurisaki et al., 1998) . Mice lacking ADAM19 die perinatally due to defects seen in heart formation (Zhou et al., 2004) , confirming the importance of ADAM19 in heart morphogenesis. Surprisingly, while ADAM19 is expressed early during embryogenesis, no major defects in other organs or tissues where ADAM19 is expressed were described, suggesting functional compensation. The heart defects were shown to be due to a lack of the ADAM19 protein in cardiac neural crest cells rather than in the endothelial cells (Komatsu et al., 2007) . The cardiac neural crest cell migration was not affected by the lack of ADAM19, however, the ability of the cells to participate in heart morphogenesis was inhibited. In Xenopus, a reduction of ADAM19 protein has some profound effects on early gene expression in the gastrula, neurula an early tailbud stage. We also find decrease expression of molecular marker during heart formation (data not shown), suggesting that ADAM19 is also involved in heart morphogenesis in amphibians, but focused on the analysis of early phenotypes. It is interesting to note that ADAM12 (meltrin-a) was not found during early embryogenesis in X. laevis, while ADAM9 and ADAM13 are both expressed in overlapping patterns with ADAM19 (Alfandari et al., 1997; Cai et al., 1998) . This suggests that X. laevis may be a good model to study the function of ADAM19 in early embryogenesis with less functional compensation than in the mouse.
Early phenotype of ADAM19
A reduction of ADAM19 in gastrula stage embryos results in a decrease of Brachyury expression in the notochord and an increase of the dorsal markers, Goosecoid and Chordin. This result is consistent with the observation that upregulation of Goosecoid can repress Brachyury expression (Boucher et al., 2000) . Thus ADAM19, which is expressed in the Spemann's Organizer, may participate in restricting Goosecoid expression. On the other hand, ADAM19 may be important to maintain Brachyury expression in the notochord. At the moment, it is not clear whether Goosecoid overexpression is preventing Brachyury expression in the notochord or if these are independently affected by ADAM19. It was previously shown that high doses of TGF-b induce Goosecoid and Chordin and repress Brachyury (Latinkic and Smith, 1999; Latinkic et al., 1997) , thus ADAM19 knock-down may increase TGF-b signaling in the embryo. This would mean that ADAM19 function is to reduce TGF-b signaling. In mouse, ADAM12 has been shown to promote TGF-b signaling by associating with the type II receptor and controlling its subcellular localization (Atfi et al., 2007) . It is therefore possible that ADAM19 also interacts with the TGF-b receptor but decreases rather than increases its signaling. Recently, EGF-CFC/FLR1, also known as crypto, was shown to modulate TGF-b signaling by nodal related proteins (Cheng et al., 2003; Dorey and Hill, 2006; Yabe et al., 2003) . Cleavage of FLR-1 by ADAM19 may reduce this signaling at the end of gastrulation when the mRNA for FLR-1 disappears. Thus there are several possible ways that ADAM19 may control TGF-b signaling at gastrulation. Whatever the mechanism of ADAM19 regulation of gene expression, the ratio between Brachyury and Chordin expression in the notochord, as been shown to control the antero/posterior identity of notochord cells. Chordin defines the anterior while Brachyury defines the posterior (Ninomiya et al., 2004) . This suggests that embryos with reduced ADAM19 have notochords that are anteriorized compare to wild-type embryos. This may in turn alter the patterning of the neural tube in a similar fashion.
To date, the best characterized signaling pathway for ADAM19 is the one involving EGF receptors (Blobel, 2005) . ADAM19 has been shown in mice to cleave some members of the EGF family including neuregulin-1b (NRG1b), which is expressed in Xenopus as a maternal transcript. Zygotic expression begins during gastrulation and continues through tailbud formation (Chung and Chung, 1999; Yang et al., 1999 Yang et al., , 1998 . Purified recombinant NRG1b can induce animal cap cells to become mesoderm and express Brachyury (Chung and Chung, 1999) . It is therefore possible that ADAM19 medi-ated cleavage of NRG1b in the dorsal blastopore lip is critical for maintaining Brachyury expression in the notochord. Neuregulins signal through the EGF receptor ErbB tyrosine kinase, and this signaling pathway has been shown to contribute to convergent and extension movements during gastrulation. However, a knock-down of ErbB3 or ErbB4 did not inhibit Brachyury expression in the notochord, suggesting that ADAM19 function may act through a different pathway Chang, 2006, 2007a,b) . On the other hand, we found that ADAM19 knock-down decrease pAKT a known target of the EGF signaling pathway. In addition, the EGF receptor inhibitor AG1478 affects neural crest gene expression in a way similar to that of the ADAM19 knock-down suggesting that ADAM19 is important for EGF activation and that this pathway is critical for neural crest cell induction.
Finally, using various markers for the notochord, paraxial mesoderm and neural ectoderm, we have found that the separation between the axial and paraxial tissues may be delayed or impaired in embryos with reduced ADAM19 protein. Given the growing role of ADAM proteins in cleaving cadherins, it is also possible that ADAM19 is involved in separating the axial from paraxial mesoderm by cleaving cell adhesion molecules such as protocadherins. The role of the protocadherins AXPC and PAPC in notochord and somite formation has been elegantly demonstrated in Xenopus (Chen and Gumbiner, 2006; Kim et al., 2000 Kim et al., , 1998 Kuroda et al., 2002; Medina et al., 2004; Unterseher et al., 2004; Wang et al., 2008) and it is possible that the activity of these proteins is regulated by proteolytic processing.
3.3.
Late phenotype of ADAM19 MO During neurulation and tailbud formation, embryos with reduced ADAM19 protein show a reduction of N-tubulin and NRP1 in the neural tissue and MLC in the somites. Interestingly, for both the dorsal mesoderm and neural tissue, the overall induction is not affected as shown by the expression of Sox2 in the neural tube and MyoD in the dorsal mesoderm, suggesting that ADAM19 may act as a modifier rather than a master controller of cell fate. ADAM19 knock-down reduces CNC cell markers xTwist, Sox8, Slug and ADAM11. In situ hybridization using xTwist reveals that at least some CNC maintain xTwist expression and are capable of migration. Together with the mouse ADAM19 KO, these results suggest that ADAM19 may be required both for neural crest cell induction and function. In addition we have shown that CNC with reduced level of ADAM19 do not migrate as efficiently as wild-type cells in vivo. This could be due to either a direct affect on migration or the observed defect in neural crest induction. Additional experiments are required to test these two hypotheses. Once again, neuregulin appears as an attractive candidate as a substrate for ADAM19 as it has been shown to induce both neural and muscle specific markers in Xenopus animal cap assays (Chung and Chung, 1999) . Moreover, the role of NRG1 in neuronal cell specification has been studied extensively (Britsch et al., 1998; Cameron et al., 2001) .
In the somitic mesoderm, a reduction of ADAM19 protein does not prevent induction and metamerization. In addition, the fibronectin rich extracellular matrix is deposited at the intersomitic boundary. While the general organization of somitic mesoderm does not depend on ADAM19, cell organization within each somite appears to be affected by a reduction of ADAM19 protein. In particular, the phenotype suggests that cell rotation may be delayed or abnormal. Together with somite organization, at least two markers of muscle differentiation (MLC and 12-101) are reduced in morphant embryos. It is not clear at the moment whether the effect on cell organization and muscle differentiation are linked. As for the early phenotype (gastrulation) both a signaling role of ADAM19 or a structural role via cleavage of a cell adhesion molecule could account for the defects seen following ADAM19 knock-down. Loss of function and complementation experiments using the putative substrates for ADAM19 will be necessary to determine which of the signaling pathways ADAM19 regulates. The Xenopus system may provide a unique way to dissect in vivo the role of ADAM19 in early embryonic development.
4.
Material and methods
Embryo culture
Xenopus laevis eggs were fertilized and the resultant embryos were dejellied in 2% cysteine and cultured as previously described (Newport and Kirschner, 1982) . Staging of embryos was according to (Nieuwkoop and Faber, 1967) .
Cloning of ADAM19
Degenerate oligonucleotide primers were designed from sequences conserved in human, mouse, quail and Xenopus tropicalis. PCR was carried out with cDNA from stage 20, stage 36 and adult liver using S1 (amino acids LNIRIAL) and AS3 (amino acids CNNNKN) at an annealing temperature of 50°C. The corresponding PCR product was cloned into TOPO-TA (Invitrogen) and sequenced. Specific primers were designed and used in 5 0 -and 3 0 -RACE-PCR with the Generacer kit (Invitrogen) according to the manufacturer's instructions. Clones from at least 3 independent PCR reactions were sequenced to obtain the full-length ADAM19.
Quantitative PCR
Total RNA was isolated from 5 embryos according to (Chomczynski and Sacchi, 1987) followed by LiCl precipitation and poly A purification using the Oligotex kit (Quiagen) according to the manufacturer instructions. The cDNA was reversed transcribed using the Quantum Qscript kit (Quanta Biosciences). All PCR reactions were carried out using Sybr green (Takara) on a MX3005P light cycler (Stratagene). All experiments were repeated at least 3 times on separate injection days and the real-time PCR was also performed in triplicate on separate days to maximize variation due to PCR efficiency. The results were analyzed using the 2 ðÀDC T method (Livak and Schmittgen, 2001) and are presented as the Log2 fold change. All data were normalized using a-tubulin. The list of the real-time PCR primers is given in Table 1 .
Plasmid constructs and mRNA microinjection
Full-length Xenopus ADAM19 was amplified by PCR using 2.5 U of Pfu DNA polymerase (Stratagene) and cloned into the pCS2 + vector (Turner and Weintraub, 1994) . Rescue ADAM19 mRNA was generated using a sense oligonucleotide containing 4 nucleotide silent mutations at the MO binding site (5 0 -CATGGAAGGTGCAACAGGAGTC-3 0 , mutation are in bold). Non-rescue ADAM19 mRNA corresponds to the original cDNA sequence. The pCS2-ADAM19 construct was linearized by NotI and transcribed by SP6 RNA polymerase. All mRNA was prepared for microinjection as described in (Cousin et al., 2000) . Transcripts (0.3 or 1 ng total) were injected close to the animal pole region of one blastomere at the two-cell stage. The uninjected half of the embryo served as an internal control for each embryo.
Antisense morpholino experiments
An antisense MO was synthesized (Gene Tools Carvalis, OR) just upstream of the ATG start codon for ADAM19 (MO19). The sequence was selected to be complementary MO19 (50-1 ng) were injected in 5 nl volume into wild-type embryos to test for toxicity. A dose of 10 ng of MO19 was selected and was shown to inhibit translation of 1 ng of the wild-type ADAM19 mRNA in embryos while allowing translation of a messenger containing the 4 nt mismatch. When the MO where injected in a subset of cells to target specific tissues, b-galactosidase or GFP-myc RNA was injected to trace the lineage with reduced ADAM19 protein.
Whole mount b-galactosidase detection and in situ hybridization
Embryos were fixed in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA pH 8, 1 mM MgSO4 and 3.7% formaldehyde) for 1 h at 20°C. They were washed in PBS and stained at 37°C in PBS solution containing 1 mg/ml X-gal, 20 mM K 3 Fe(CN) 6 , 20 mM K 4 Fe(CN) 6 and 2 mM MgCl 2 . The embryos were dehydrated in methanol and stored at À20°C. Whole mount in situ hybridization was performed exactly as described previously using albino or wild-type embryos (Harland, 1991) .
Antibody preparation
Two glutathione S-transferase (GST) fusion proteins were prepared by cloning both variants of cDNA encoding the COOH-terminal amino acid residues of the XADAM19 cytoplasmic domains into the pGEX-KG vector (Guan and Dixon, 1991) . Fusion proteins were purified using standard methods, combined with complete Freund's adjuvant and injected into New Zealand white rabbits. Immune IgG were purified on a His-tag fusion protein (pET vectors, Novagen) column containing the same COOH-terminal amino acid residues used for immunization (NHS-sepharose, Pharmacia). Purified IgG (Ab A19) were stored at concentrations of 1 mg/ml in 50% glycerol at À20°C.
Western blot analysis
Embryo protein extraction and Western blot analysis were performed exactly as described previously (Alfandari et al., 1997) . Monoclonal antibody to PACSIN2 (3D8) was used as a loading control as described previously (Cousin et al., 2000) . For quantification, blots were detected using chemiluminescence on a G-Box HR16 (Syngene) and analyzed using the Genetool analysis software. Alternatively for weaker signals, the blots were exposed on X-ray films for various time points and the films were scanned and analyzed by densitometry using the same software.
4.9.
Immunofluorescence and whole mount immunostaining
Embryos were fixed using either MEMFA or DENTS (20% DMSO in 80% methanol) and stored in methanol before sectioning. Embedding was performed by increasing doses of 15% fish skin gelatin (Sigma) and 15% sucrose in PBS. After a final impregnation overnight at 4°C, embryos were mounted in OCT (Tissue Teck). Cryosections (14-16 lm) were blocked in PBS containing 20% goat serum and 1% BSA (Sigma). Primary antibodies were used at 10 lg/ml and secondary antibodies (Jackson Immunoresearch) were used at 5 lg/ml. Slides were mounted using Vectashield (Vector) and imaged using a Zeiss Axiovert 200 M inverted microscope equipped with a Ludl XY-stage control and a Hamamatsu Orca camera. Images were taken using the ApoTome structured light illumination system (Zeiss) and the AxioVision software (Zeiss). Whole mount immunostaining was performed as previously described (Dent et al., 1989) .
Time-lapse imaging
Embryos at late blastula stage were individually placed in holes made in an agarose coated plastic dish. Time-lapse movies were made using an Axiovert inverted microscope (Zeiss) equipped with a Ludl XY-stage control and an Orca camera (Hamamatsu) and controlled by the Openlab software (Improvision). Measurements were done using the same software.
